Tom Wei-Wu Chen
@saxotomy
Followers
970
Following
2K
Media
138
Statuses
1K
Dedicated sarcoma and breast medical oncologist from Taiwan. (National Taiwan University Hospital and Cancer Center)
Taiwan
Joined April 2010
Thanks to Dr. Scott Okuno for the opportunity to write the review on the #immunotherapies for #angiosarcoma.
0
3
18
RT @herbloong: 📢To all @ctosociety #sarcoma #peeps! The #CommunicationsCommittee wants to know what YOUR preferences are when it comes to #….
0
5
0
RT @JSMO_official: #JSMO25 国際展示場2号館1階の企業展示に Taiwan Oncology Society（TOS）ブースを設置しております。The 29h Taiwan Joint Cancer Conferenceもご紹介しておりますので，ぜひ….
0
1
0
For all #sarcoma #enthusiasts. One month to the #ATLAS #Sarcoma Webinar by Dr. Valerie Yang of #NCCS and Dr. JC Lee of #NTUH. Register and book your calendar! Look forward to seeing you online!.
🌟"ATLAS Monthly Webinar" series🌟.We are excited to announce the ATLAS Monthly Webinar! This seminar series aims to share the latest advancements in cancer research, and treatment. We look forward to your participation😊.Date: 2025/03/27.Registration:
0
4
18
RT @JTrentMDPhD: FDA Approves Vimseltinib for Symptomatic Tenosynovial Giant Cell Tumor. Vimseltinib achieved a 40% ORR in #TGCT patients,….
0
6
0
RT @VivekSubbiah: Results of a phase Ib study of olaparib with concomitant radiotherapy in soft-tissue sarcoma: a French sarcoma group stud….
0
6
0
RT @stern_sydney: It is #RareDisease Month!🦓 There are > 7,000 rare diseases & 1 in 10 Americans have a rare disease. About half of rare di….
0
1
0
Congrats! A big step in #immunotherapy for #sarcoma especially for visceral #angiosarcoma which typically unlikely to respond #ICI combinations! Looking forward to see future studies for validation!.
Very excited to see this in print! Such promising outcomes for immune cold #sarcomas with Botensilimab Plus Balstilimab @Agenus_Bio @CUCancerCenter.
0
2
11
RT @ZaZa_Othman: Amazing numbers for #ESMOAsia24 🎉. We couldn’t have done it without all the support from the #oncology community! ✨💕.
0
4
0
RT @alegronchi: Hey, watch out. here is a nice recap of the best published studies in 2023/2024 in #sarcoma Thanks to all the investigato….
0
41
0
RT @ctosociety: #CTOS2024 came to an end!.Thank you for participating and all the social media interactions! And please save the date for t….
0
12
0
RT @pawel_sobczuk: Elegant presentation on alternative lenghtening of telomerase in #sarcoma PDXs by @AgaWozniak1.#CTOS2024 @ctosociety #cT….
0
2
0
#PUSH Pushing Ultra-rare Sarcomas towards Hope!.
Great #CTOS 2024 Annual Meeting in San Diego!.Always a unique time for ideas exchange and meeting new and old friends from all around the world. Looking forward for future steps in #sarcoma research!.#PUSH .@merlini_ale @SilviaStacchia @WTapMD @saxotomy @herbloong @alegronchi
0
3
14
RT @srothschild: Great research on SDH-deficient #GIST from @UCSDCancer on DR-5 agonist INBRX-109 in combination with TMZ #CTOS2024 looking….
0
5
0
RT @priyachudasama5: Thank you #CTOS2024 organizing committees for the opportunity to present our project on uncovering fusion oncoprotein-….
0
1
0
RT @pawel_sobczuk: @bvantine1 presenting the results of SUNRISELMS trial of unesbulin+dacarbazine.❌study was closed prematurely at the inte….
0
5
0
RT @priyachudasama5: @DKirschMDPhD presenting the results of SARC032 trial, favoring addition of pembrolizumab to preoperative radiotherapy….
0
5
0
0
2
18
The #gist deabte to early combo or not is on #CTOS2024 @Liferaftgroup @ctosociety @seppobauer & Margret von Mehren
1
6
19